Baxter International Inc Stock News

In this article you are going to find out whether hedge funds think Baxter International Inc. (NYSE:BAX) is a good investment right now. We like to check what the smart money thinks first before doing

Vaxcyte has filed to raise $100 million in an IPO, although the final figure may differ. The firm is developing vaccines for a number of disease conditions. PCV

The

Former US vice president's firm releases 1st-quarter portfolio Continue reading...

One more amicus, Baxter International, has submitted its brief in support of Chrimar, followed by ALE’s brief in opposition to the petition, in Chrimar System Inc.'s petition to the Supreme Court fo

Firm's largest buys of the 1st quarter Continue reading...

With 27 new Patent Trial and Appeal Board (PTAB) filings—25 inter partes reviews (IPRs), one post grant review (PGR) and one covered business method review (CBM), the first in months—this week’s

Baxter (BAX) receives the CE marking and regulatory approval for the Evo IQ Syringe Infusion system that will help in optimizing efficiency for clinicians.

RMB Capital Management LLC increased its stake in Baxter International Inc (NYSE:BAX) by 5.1% during the first quarter, Holdings Channel.com reports. The firm owned 5,432 shares of the medical instrum

May 25, 2020 (CDN Newswire via Comtex) -- Global Prepackaged Medical Kits and Tray Market 2020 by Company, Regions, Type and Application, Forecast to 2026...

The

May 25, 2020 (Market Insight Reports) -- Selbyville, Delaware According to Market Study Report, Inhalation Anesthesia Market provides a comprehensive...

CHICAGO, May 25, 2020 /PRNewswire via COMTEX/ -- CHICAGO, May 25, 2020 /PRNewswire/ -- According to the new market research report "European Medical Devices...

SAN FRANCISCO, May 25, 2020 /PRNewswire via COMTEX/ -- SAN FRANCISCO, May 25, 2020 /PRNewswire/ -- The global tissue engineering market size is expected to...